Details of Protein
| General Information of Protein (ID: PRT01557) | |||||
|---|---|---|---|---|---|
| Name | Glyoxylate reductase/hydroxypyruvate reductase (GRHPR) | ||||
| Synonyms |
Click to Show/Hide Synonyms of This Protein
MSTP035; GRHPR; GLXR
|
||||
| Gene Name | GRHPR | Gene ID | |||
| UniProt ID | |||||
| Family | Oxidoreductases (EC 1) | ||||
| EC Number | EC: 1.1.1.79 (Click to Show/Hide the Complete EC Tree) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
| Sequence |
MRPVRLMKVFVTRRIPAEGRVALARAADCEVEQWDSDEPIPAKELERGVAGAHGLLCLLS
DHVDKRILDAAGANLKVISTMSVGIDHLALDEIKKRGIRVGYTPDVLTDTTAELAVSLLL TTCRRLPEAIEEVKNGGWTSWKPLWLCGYGLTQSTVGIIGLGRIGQAIARRLKPFGVQRF LYTGRQPRPEEAAEFQAEFVSTPELAAQSDFIVVACSLTPATEGLCNKDFFQKMKETAVF INISRGDVVNQDDLYQALASGKIAAAGLDVTSPEPLPTNHPLLTLKNCVILPHIGSATHR TRNTMSLLAANNLLAGLRGEPMPSELKL |
||||
| Structure | |||||
| Function | Enzyme with hydroxy-pyruvate reductase, glyoxylate reductase and D-glycerate dehydrogenase enzymatic activities. Reduces hydroxypyruvate to D-glycerate, glyoxylate to glycolate oxidizes D-glycerate to hydroxypyruvate. | ||||
| Regulatory Network | |||||
| Full List of Metabolite(s) Regulated by This Protein | ||||||
|---|---|---|---|---|---|---|
| Lipids and lipid-like molecules | ||||||
| Adipic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Adipic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of adipic acid levels compared with control group. | |||||
| Organic acids and derivatives | ||||||
| (S)-3-Hydroxyisobutyric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | (S)-3-Hydroxyisobutyric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of (S)-3-hydroxyisobutyric acid levels compared with control group. | |||||
| 3-Aminoisobutanoic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | 3-Aminoisobutanoic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of 3-aminoisobutanoic acid levels compared with control group. | |||||
| 3-Hydroxybutyrate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | 3-Hydroxybutyrate concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of 3-hydroxybutyrate levels compared with control group. | |||||
| Cystine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Cystine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of cystine levels compared with control group. | |||||
| Hydroxypropionic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Hydroxypropionic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of hydroxypropionic acid levels compared with control group. | |||||
| Lysine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Lysine concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of lysine levels compared with control group. | |||||
| Oxalic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Oxalic acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of oxalic acid levels compared with control group. | |||||
| Organic oxygen compounds | ||||||
| Glyceric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
| Detailed Information |
Metabo Info
click to show the details of this metabolite
|
|||||
| Regulating Pair |
Experim Info
click to show the details of experiment for validating this pair
|
[1] | ||||
| Introduced Variation | Mutation (patients: c.454dup (p.Thr152Asnfs*39)) of GRHPR | |||||
| Induced Change | Glyceric acid concentration: increase | |||||
| Summary | Introduced Variation
|
|||||
| Disease Status | Carbohydrate metabolism disorders [ICD-11: 5C51] | |||||
| Details | It is reported that mutation (patients with c.454dup (p.Thr152Asnfs*39)) of GRHPR leads to the increase of glyceric acid levels compared with control group. | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism. BMC Med Genet. 2017 May 31;18(1):59. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.

